欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	AT/H/0716/002
药品名称	Olmeblo
活性成分	olmesartan medoxomil 10.0 mg
剂型	Film-coated tablet
上市许可持有人	G.L. Pharma GmbH Schlossplatz 1, Lannach 8502 Austria
参考成员国 - 产品名称	Austria (AT) Olmeblo 10 mg Filmtabletten
互认成员国 - 产品名称
许可日期	2016/07/25
最近更新日期	2022/03/09
药物ATC编码	C09CA08 olmesartan medoxomil
申请类型	TypeLevel1：[not specified] TypeLevel2：[not specified] TypeLevel3：[not specified] TypeLevel4：[not specified] TypeLevel5：[not specified]
附件文件下载	Final Labelling \| KE_AT_H_0716_001_R_001_final-Olmeblo5mgDate of last change:2019/06/05 Final Labelling \| KE_AT_H_0716_004_R_001_final-Olmeblo40mgDate of last change:2019/06/05 Final Labelling \| KE_AT_H_0716_002_R_001_final-Olmeblo10mgDate of last change:2019/06/05 Final Labelling \| KE_AT_H_0716_003_R_001_final-Olmeblo20mgDate of last change:2019/06/05 Final PL \| GI_AT_H_0716_002_R_001_final-Olmeblo10mgDate of last change:2019/06/05 Final PL \| GI_AT_H_0716_001_R_001_final-Olmeblo5mgDate of last change:2019/06/05 Final PL \| GI_AT_H_0716_003_R_001_final-Olmeblo20mgDate of last change:2019/06/05 Final PL \| GI_AT_H_0716_004_R_001_final-Olmeblo40mgDate of last change:2019/06/05 Final SPC \| FI_AT_H_0716_001-004_R_001_final-OlmebloDate of last change:2019/06/05
市场状态	Positive